MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRESNICK, E.
Right arrow Articles by MOSSÉ, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRESNICK, E.
Right arrow Articles by MOSSÉ, H.

Molecular Pharmacology, Vol 5, 219-226, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Activation of Genetic Transcription in Rat Liver Chromatin by 3-Methylcholanthrene

EDWARD BRESNICK 1 and HELENE MOSSÉ 1

1 Department of Pharmacology, Baylor University College of Medicine, Houston, Texas 77025

Previous studies had indicated that the administration of 3-methylcholanthrene to rats is attended by an increase in the "aggregate" RNA polymerase activity in rat liver. Chromatin has been isolated from the livers of both control and 3-methylcholanthrene-treated rats. The experimental chromatin did not differ from control material in RNA:DNA and histone to DNA ratios, ultraviolet absorption, or transition temperature. The efficacy of the chromatin as a template was determined in the Micrococcus lysodeikticus RNA polymerase system. The liver chromatin from 3-methylcholanthrene-treated rats proved to be a better template. Adrenalectomy did not affect this finding. The nearest neighbor frequency of the RNA elaborated on the chromatin template was also determined. The RNA product made in the presence of chromatin isolated from 3-methylcholanthrene-treated rats differed substantially from that made in the presence of control chromatin or rat liver DNA itself. These studies provide further evidence that the administration of the polycyclic hydrocarbon leads to an activation of a region(s) on the genome.

Submitted on December 16, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics